Reis G, dos Santos Moreira-Silva EA, Medeiros Silva DC, et al. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial. Lancet Glob Health 2021; 10: e42–51—In table 3 of this Article, in the “adherence” row, the estimated treatment effect should read “0·62 (0·48–0·77)”. Appendix 2 of this Article has also been corrected. These corrections have been made as of Feb 24, 2022.
. 2022 Feb 24;10(4):e481. doi: 10.1016/S2214-109X(22)00081-X
Correction to Lancet Glob Health 2021; 10: e42–51
Issue date 2022 Apr.
© 2022 The Author(s). Published by Elsevier Ltd.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC8871408 PMID: 35219356